1818

MRI-detected extramural vascular invasion is a strong risk factor in predicting synchronous distant metastasis in rectal cancer
Pratik Tripathi1,2, Shengxiang Rao2, Weifeng Guo2, Bimal Rai1, Mengsu Zeng2, and Daoyu Hu1

1Department of Radiology, Tongji Medical College, HUST, Wuhan, China, 2Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China

Synopsis

MRI detected extramural vascular invasion (mrEMVI) is potential imaging predictive biomarker for selecting optimum treatment method and is closely correlated with poor prognosis. Several studies have been done to understand the correlation between EMVI and metastasis, but not synchronous metastasis to be specific. We aimed to analyze the correlation between clinical factors including mrEMVI with synchronous metastasis. Moreover, we analyzed the correlation between grades of mrEMVI and synchronous metastasis.

Purpose

Extramural vascular invasion (EMVI) is an independent prognostic factor for poor overall survival rate in rectal cancer. We aim to evaluate the MRI-detected extramural vascular invasion (mrEMVI) in predicting synchronous distant metastasis in T3 rectal cancer.

Methods and Materials

Post-operative histopathologically confirmed T3 rectal cancer patients who underwent preoperative MRI without previous treatment were enrolled for this study. Two blinded radiologists evaluated location of the tumor, the degree of mesorectal extension and mrEMVI. mrEMVI was further categorized into EMVI positive and EMVI negative using mrEMVI scoring system in T2 weighted image. The results along with other clinical characteristics (age, sex, tumor location, MRI detected distance of mesorectal extension, lymphatic invasion, perineural invasion, mrEMVI score and CEA) were then correlated with synchronous metastases to determine the risk factors using univariate and multivariate analysis.

Results

Among 180 patients, 38 patients were confirmed to be mrEMVI-positive, 34 patients with synchronous metastasis in which 25 were mrEMVI-positive and 9 were mrEMVI-negative. Three factors were significantly associated with synchronous metastasis: mrEMVI (p=0.001), histopathological lymphatic invasion (p=0.001) and preoperative CEA (p=0.026). mrEMVI score 4 was more liable for synchronous metastasis (p=0.044) than mrEMVI score 3 in rectal cancer.

Conclusion

There is an intimate relationship between mrEMVI and synchronous metastasis in rectal cancer. mrEMVI positive is an independent risk factor for synchronous distant metastasis in rectal cancer. mrEMVI score 4 is a strong risk factor for synchronous metastasis than mrEMVI score 3 in rectal cancer.

Acknowledgements

The manuscript is original work of author. All data, tables, figures, etc. used in the manuscript are prepared originally by authors, otherwise the sources are cited and reprint permission is attached. Authors mention that there is no conflict of interest in this study.

References

1. Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008; 95: 229–236. doi:10.1002/bjs.5917

2. Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJR, Morson BC. Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology 1981; 5: 141–163.

3. Chand M, Evans J, Swift RI et al. The Prognostic Significance of Postchemoradiotherapy High-resolution MRI and Histopathology Detected Extramural Venous Invasion in Rectal Cancer. Ann Surg 2015; 261: 473–9. doi:10.1097/SLA.0000000000000848

4. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJR, Morson BC. The clinical significance of invasion of veins by rectal cancer. Br J Surg 1980; 67: 439–442. doi:10.1002/bjs.1800670619

5. Günther K, Dworak O, Remke S et al. Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 2002; 103: 68–78. doi:10.1006/jsre.2001.6312

6. Sohn B, Lim J-S, Kim H et al. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol 2015; 25: 1347–1355. doi:10.1007/s00330-014-3527-9

7. Brown G, Radcliffe a G, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90: 355–64. doi:10.1002/bjs.4034

8. Tripathi P, Rao SX, Zeng MS. Clinical value of MRI-detected extramural venous invasion in rectal cancer. J Dig Dis 2016; 18: 2–12. doi:10.1111/1751-2980.12439

9. Kim JS, Sohn DK, Park JW et al. Prognostic significance of distribution of lymph node metastasis in advanced mid or low rectal cancer. J Surg Oncol 2011; 104: 486–492. doi:10.1002/jso.21966

10. Rasheed S, Bowley DM, Aziz O et al. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers. Color Dis 2008; 10: 231–237. doi:10.1111/j.1463-1318.2007.01411.x

11. Batsakis JG. Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol 1985; 94: 426–427.

12. Zhou Y, Wang H, Gong H, Cao M, Zhang G, Wang Y. Clinical significance of perineural invasion in stages II and III colorectal cancer. Pathol Res Pr 2015; 211: 839–844. doi:10.1016/j.prp.2015.09.001

13. Vukobrat-Bijedic Z, Husic-Selimovic A, Sofic A et al. Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma. Med Arch (Sarajevo, Bosnia Herzegovina) 2013; 67: 397–401. doi:10.5455/medarh.2013.67.397-401

14. Ghiringhelli F, Hennequin A, Drouillard A, Lepage Cô, Faivre J, Bouvier AM. Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: A French population-based study. Dig Liver Dis 2014; 46: 854–858. doi:10.1016/j.dld.2014.05.011

15. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638–46. doi:10.1056/NEJMoa010580

16. Nagtegaal ID, van de Velde CJH, Marijnen C a M, van Krieken JHJM, Quirke P. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23: 9257–64. doi:10.1200/JCO.2005.02.9231

17. Cho SH, Kim SH, Bae JH et al. Prognostic stratification by extramural depth of tumor invasion of primary rectal cancer based on the Radiological Society of North America proposal. Am J Roentgenol 2014; 202: 1238–1244. doi:10.2214/AJR.13.11311

18. Pratik T, Guo W, Yang C, Bimal R, Zeng M. Clinical feasibility assessment of T3 sub-stage in rectal cancer using MRI. Iran J Radiol 2018; 15. doi:10.5812/iranjradiol.16801

19. Mekenkamp LJM, Koopman M, Teerenstra S et al. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. Br J Cancer 2010; 103: 159–64. doi:10.1038/sj.bjc.6605737

20. Lam AKY, Carmichael R, Gertraud Buettner P, Gopalan V, Ho YH, Siu S. Clinicopathological significance of synchronous carcinoma in colorectal cancer. Am J Surg 2011; 202: 39–44. doi:10.1016/j.amjsurg.2010.05.012

21. Villeneuve PJ, Sundaresan RS. Surgical management of colorectal lung metastasis. Clin Colon Rectal Surg 2009; 22: 233–241. doi:10.1055/s-0029-1242463

22. Liu L, Liu M, Yang Z, He W, Wang Z, Jin E. Correlation of MRI-detected extramural vascular invasion with regional lymph node metastasis in rectal cancer. Clin Imaging 2016; 40: 456–460. doi:10.1016/j.clinimag.2016.01.007

23. Yu X ping, Wen L, Hou J et al. Discrimination between metastatic and nonmetastatic mesorectal lymph nodes in rectal cancer using intravoxel incoherent motion diffusion-weighted magnetic resonance imaging. Acad Radiol 2016; 23: 479–485. doi:10.1016/j.acra.2015.12.013

24. Märkl B, Rößle J, Arnholdt HM et al. The clinical significance of lymph node size in colon cancer. Mod Pathol 2012; 25: 1413–1422. doi:10.1038/modpathol.2012.92

25. Ishibe A, Ota M, Watanabe J et al. Prediction of Lateral Pelvic Lymph-Node Metastasis in Low Rectal Cancer by Magnetic Resonance Imaging. World J Surg 2016; 40: 995–1001. doi:10.1007/s00268-015-3299-7

26. Al-Sukhni E, Milot L, Fruitman M et al. Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol 2012; 19: 2212–2223. doi:10.1245/s10434-011-2210-5

27. Wu Y, Jin M, Xu H et al. Clinicopathologic significance of HIF-1alpha, CXCR4, and VEGF expression in colon cancer. Clin Dev Immunol 2010; 2010. doi:10.1155/2010/537531

28. Esposito DL, Aru F, Lattanzio R et al. The insulin receptor substrate 1 (irs1) in intestinal epithelial differentiation and in colorectal cancer. PLoS One 2012; 7. doi:10.1371/journal.pone.0036190

29. Ayaki M, Komatsu K, Mukai M et al. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clin Cancer Res 2001; 7: 3106–3112.

Figures

Schematic illustration of MRI predicted EMVI and mrEMVI score[8]

a. Pattern of tumor extension through the rectal wall is not nodular; no obvious adjacent vessels are seen in T2WI (mrEMVI-negative; mrEMVI score 0)

b. Minimal extramural stranding; no adjacent vessels are seen in T2WI, normal caliber vessel is only seen (white arrow) mrEMVI-negative; MRI mrEMVI 1

c. Stranding in proximity of vessels but no tumor signal in normal caliber lumen seen in T2WI (white arrow) mrEMVI-negative; mrEMVI score 2

d. Intermediate signal in lumen of vessels; slight vessel expansion seen in T2WI (white arrow) mrEMVI-positive; mrEMVI score 3

e. Irregular vessel contour; definite tumor signal seen in T2WI (white arrow) mrEMVI-positive; mrEMVI score 4


a. CEA level vs. synchronous metastasis; the pre-operative high CEA can be seen with obvious high hepatic metastasis compared with normal CEA level.

b. Lymphatic invasion status vs. synchronous metastasis; positive histopathological lymph node invasion population showed more metastasis compared to negative lymph node invasion.

c. mrEMVI score vs. synchronous metastasis; increase in metastasis with respect to the mrEMVI score can be seen in the figure above, hepatic metastasis can be seen comparatively more in mrEMVI positive (score 3 and 4)


Proc. Intl. Soc. Mag. Reson. Med. 27 (2019)
1818